Eli Lilly Launches Employer Connect to Bridge Obesity Drug Coverage Gap for Millions of Workers

Eli Lilly and Company launched its Employer Connect platform on March 5, 2026. This initiative increases employee access to obesity medications through employer-sponsored health plans.

Approximately 50% of commercially insured employees currently lack insurance coverage for obesity treatments. The platform aims to address this gap by partnering with more than 15 independent program administrators, including GoodRx and Mark Cuban Cost Plus Drug Company.

The network offers flexible benefit designs for employers. It makes Lilly’s weight-loss drug, Zepbound, available at a discounted price to employees of participating companies.